According to a recent research report titled ” Generative AI in Drug Discovery Market (By Technology: Machine Learning, Reinforcement Learning, Deep Learning, Molecular Docking, Quantum Computing; By End User: Pharmaceutical & Biotechnology Company, Academic & Research Institution, Contract Research Organizations, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032″ published by Precedence Research, the global generative AI in drug discovery market size is projected to touch around USD 1,417.83 million by 2032 and growing at a CAGR of 27.38% over the forecast period 2023 to 2032. This comprehensive study examines various factors and their impact on the growth of the GENERATIVE AI IN DRUG DISCOVERY market.
Key Takeaways:
- North America contributed more than 50% of revenue share in 2022.
- By technology, the deep learning segment is expected to capture a significant market share over the forecast period.
- By end user, the pharmaceutical & biotechnology company segment generated more than 43% of revenue share in 2022.
The report primarily focuses on the volume and value of the GENERATIVE AI IN DRUG DISCOVERY market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.
Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3129
The research also highlights significant progressions in both organic and inorganic growth strategies within the global generative AI in drug discovery market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the generative AI in drug discovery market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.
Generative AI in Drug Discovery Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 160.59 Million |
| Market Size by 2032 | USD 1,417.83 Million |
| Growth Rate from 2023 to 2032 | CAGR of 27.38% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Technology and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: Polyvinyl Butyral Market Size to Record US$ 8.06 billion by 2032
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
Market Key Players
The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the generative AI in drug discovery market.
Some of the prominent players in the generative AI in drug discovery market include
- Insilico Medicine
- Atomwise Inc.
- BenevolentAI
- XtalPi Inc
- Numerate Inc
- Cyclica Inc
- BioSymetrics
- Variational AI Inc.
- Merck KGaA
- NVIDIA
Generative AI in Drug Discovery Market Segmentations
By Technology
- Machine Learning
- Reinforcement Learning
- Deep Learning
- Molecular Docking
- Quantum Computing
By End User
- Pharmaceutical & Biotechnology Company
- Academic & Research Institution
- Contract Research Organizations
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Why should you invest in this report?
This report presents a compelling investment opportunity for those interested in the global generative AI in drug discovery market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for generative AI in drug discovery. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.
Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.
Some of the key questions answered in this report:
- What is the size of the overall Generative AI in drug discovery market and its segments?
- What are the key segments and sub-segments in the market?
- What are the key drivers, restraints, opportunities and challenges of the Generative AI in drug discovery market and how they are expected to impact the market?
- What are the attractive investment opportunities within the Generative AI in drug discovery market?
- What is the Generative AI in drug discovery market size at the regional and country-level?
- Who are the key market players and their key competitors?
- What are the strategies for growth adopted by the key players in Generative AI in drug discovery market?
- What are the recent trends in Generative AI in drug discovery market? (M&A, partnerships, new product developments, expansions)?
- What are the challenges to the Generative AI in drug discovery market growth?
- What are the key market trends impacting the growth of Generative AI in drug discovery market?
Table of Content:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Generative AI in Drug Discovery Market
5.1. COVID-19 Landscape: Generative AI in Drug Discovery Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Generative AI in Drug Discovery Market, By Technology
8.1. Generative AI in Drug Discovery Market, by Technology, 2023-2032
8.1.1. Machine Learning
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Reinforcement Learning
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Deep Learning
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Molecular Docking
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Quantum Computing
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Generative AI in Drug Discovery Market, By End User
9.1. Generative AI in Drug Discovery Market, by End User, 2023-2032
9.1.1. Pharmaceutical & Biotechnology Company
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Academic & Research Institution
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Contract Research Organizations
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Generative AI in Drug Discovery Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Technology (2020-2032)
10.1.2. Market Revenue and Forecast, by End User (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Technology (2020-2032)
10.1.3.2. Market Revenue and Forecast, by End User (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Technology (2020-2032)
10.1.4.2. Market Revenue and Forecast, by End User (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology (2020-2032)
10.2.2. Market Revenue and Forecast, by End User (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Technology (2020-2032)
10.2.3.2. Market Revenue and Forecast, by End User (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Technology (2020-2032)
10.2.4.2. Market Revenue and Forecast, by End User (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Technology (2020-2032)
10.2.5.2. Market Revenue and Forecast, by End User (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)
10.2.6.2. Market Revenue and Forecast, by End User (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology (2020-2032)
10.3.2. Market Revenue and Forecast, by End User (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Technology (2020-2032)
10.3.3.2. Market Revenue and Forecast, by End User (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Technology (2020-2032)
10.3.4.2. Market Revenue and Forecast, by End User (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Technology (2020-2032)
10.3.5.2. Market Revenue and Forecast, by End User (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)
10.3.6.2. Market Revenue and Forecast, by End User (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology (2020-2032)
10.4.2. Market Revenue and Forecast, by End User (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Technology (2020-2032)
10.4.3.2. Market Revenue and Forecast, by End User (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Technology (2020-2032)
10.4.4.2. Market Revenue and Forecast, by End User (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Technology (2020-2032)
10.4.5.2. Market Revenue and Forecast, by End User (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)
10.4.6.2. Market Revenue and Forecast, by End User (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology (2020-2032)
10.5.2. Market Revenue and Forecast, by End User (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Technology (2020-2032)
10.5.3.2. Market Revenue and Forecast, by End User (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Technology (2020-2032)
10.5.4.2. Market Revenue and Forecast, by End User (2020-2032)
Chapter 11. Company Profiles
11.1. Insilico Medicine
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Atomwise Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. BenevolentAI
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. XtalPi Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Numerate Inc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cyclica Inc
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. BioSymetrics
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Variational AI Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Variational AI Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. NVIDIA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
